HCA Healthcare Inc (NYSE:HCA) Plans Quarterly Dividend of $0.40

HCA Healthcare Inc (NYSE:HCA) declared a quarterly dividend on Monday, July 29th, Zacks reports. Investors of record on Tuesday, September 3rd will be given a dividend of 0.40 per share on Monday, September 30th. This represents a $1.60 annualized dividend and a yield of 1.19%. The ex-dividend date of this dividend is Friday, August 30th.

HCA Healthcare has a dividend payout ratio of 17.3% meaning its dividend is sufficiently covered by earnings. Analysts expect HCA Healthcare to earn $11.22 per share next year, which means the company should continue to be able to cover its $1.60 annual dividend with an expected future payout ratio of 14.3%.

HCA Healthcare stock opened at $134.82 on Wednesday. HCA Healthcare has a 52 week low of $110.31 and a 52 week high of $147.42. The business’s 50-day simple moving average is $135.97. The stock has a market capitalization of $49.66 billion, a PE ratio of 13.80, a price-to-earnings-growth ratio of 1.24 and a beta of 0.80.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 30th. The company reported $2.21 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $2.49 by ($0.28). HCA Healthcare had a negative return on equity of 112.65% and a net margin of 7.71%. The business had revenue of $12.60 billion for the quarter, compared to analysts’ expectations of $12.61 billion. During the same quarter in the previous year, the firm earned $2.29 earnings per share. HCA Healthcare’s quarterly revenue was up 9.3% compared to the same quarter last year. As a group, equities analysts anticipate that HCA Healthcare will post 10.4 EPS for the current fiscal year.

Several equities analysts recently commented on the company. UBS Group restated a “sell” rating on shares of in a research report on Monday, June 24th. Jefferies Financial Group set a $158.00 target price on HCA Healthcare and gave the stock a “buy” rating in a research report on Wednesday, April 17th. Raymond James set a $86.00 target price on Gilead Sciences and gave the stock a “buy” rating in a research report on Tuesday, April 23rd. Deutsche Bank lowered Hilton Hotels from a “buy” rating to a “hold” rating and set a $92.60 price target for the company. in a research note on Wednesday, May 1st. They noted that the move was a valuation call. Finally, Goldman Sachs Group lowered EXPERIAN PLC/ADR from a “buy” rating to a “neutral” rating in a research note on Wednesday, July 10th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and seventeen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $152.85.

In other HCA Healthcare news, insider Jon M. Foster sold 44,281 shares of HCA Healthcare stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $122.28, for a total transaction of $5,414,680.68. Following the completion of the sale, the insider now owns 96,052 shares of the company’s stock, valued at $11,745,238.56. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 2.70% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: What is a price target?

Dividend History for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.